Follow-up After Abnormal Mammo Screens Tends to be Timely

AuntMinnie | How promptly a facility follows up with women who have received an abnormal mammogram is crucial to a screening mammography program’s success, according to a new study published online in Radiology. Time to follow-up varies widely between facilities — indicating there is definitely room for improvement — but most patients receive follow-up within minimum standard recommendations, researchers found.

When a breast center follows up on abnormal mammograms quickly, it can reduce patient anxiety, especially because most don’t require a biopsy. And for those who do need a biopsy, promptness is even more valuable for developing a treatment protocol, wrote lead author Dr. Robert Rosenberg, chief of mammography at University of New Mexico’s School of Medicine, and colleagues (Radiology, September 7, 2011).

“An optimal screening system would minimize the time required to complete the screening process — and thus minimize patient anxiety,” the authors wrote. “Also, while difficult to document, timely follow-up seems likely to maximize complete follow-up.”

The study team gleaned data from the Breast Cancer Surveillance Consortium (BCSC), examining screening mammograms acquired from 1996 to 2007 in women between 40 and 80 years old. Data were available on 214,897 additional imaging recommendations from 118 facilities, and more than 35,622 biopsy or surgical consultation recommendations from 101 facilities. “Facilities” included hospitals, health maintenance organizations (HMOs), private radiology offices, or hospital outpatient centers (“specialty centers”), and obstetrics and gynecology offices, primary care offices, or multispeciality clinics (“nonspecialty centers”).

The team used follow-up guidelines developed in Europe (the only published guidelines available); acceptable outcomes included 95% of patients receiving a result within 15 working days and 90% being offered follow-up within five working days.

Of the women included in the study, the majority were college educated (41.1%), did not have a family history of breast cancer (85.1%), and were seen in a hospital (44%). More than 76% had received a previous mammogram within the past 12 to 35 months.

Approximately 90% of additional imaging follow-up and 81% of biopsy or surgical consultation follow-up happened within 30 days. Median time to subsequent follow-up care after recommendation was 14 days for additional imaging and 16 days for biopsy or surgical consultation. Time to additional imaging follow-up was longest for hospital-based screening venues, while the longest times for biopsy or surgical consultation were in specialty and nonspecialty centers; the shortest times were in HMO-type facilities.

The researchers also found, unsurprisingly, that facilities with higher recall rates tended to have longer additional imaging follow-up times. Over the study period, biopsy or surgical consultation follow-up rates at 15 and 30 days improved, and timely follow-up was associated with larger volumes of the recommended procedures, but not necessarily with facility type or characteristics.

There are many reasons for follow-up delays, according to Rosenberg and colleagues. Facilities that only perform screening mammograms must refer abnormal studies elsewhere. And even if screening is performed and diagnostic mammograms are obtained at the same facility, delays can occur between imaging and interpretation, interpretation and contact of patients, and patient contact and the date of the scheduled follow-up procedure. But overall, despite rapid initial follow-up of additional imaging, the study team found that the follow-up time variation between facilities is “considerable and unexplained.”

“The average delay of 14 days for additional imaging recommendation and 16 days for a biopsy or surgical consultation recommendation are not excessive from the standpoint of the biology of cancer, but many patients experience substantial delays that may be unacceptable emotionally,” they wrote. “A persistent concern is how these delays affect women’s satisfaction and use of subsequent screening.”

Read more on AuntMinnie.com.



Kyle Henneberry, M.D.

Associate Chief Medical Officer
Dr. Kyle Henneberry is a radiologist, health-tech innovator and one of the founders and principals of Direct Radiology. A native of Spokane, Washington, he graduated with honors in Biomedical Engineering from Northwestern University, received his medical degree from Case Western Reserve University in Cleveland, Ohio, and completed radiology residency at the University of Colorado. Dr. Henneberry has United States, Europe, Australia, and New Zealand.

Jerry Lee

Chief Technology Officer

Jerry Lee has over 25 years of experience in healthcare IT. and has been with ONRAD since 2013. As the CTO, he is responsible for developing the organization’s technology strategy including IT infrastructure, application development, data analytics, cybersecurity and overall risk management. Lee’s focus is on strategic road mapping, leveraging emerging technologies and business intelligence to automate, streamline and optimize business processes. He previously worked as a senior healthcare IT consultant, where he implemented best practices, policies & procedures, and risk mitigation strategies for a variety of clients. He also previously worked as the Business Intelligence and Analytics Project Manager for a leading healthcare SaaS organization. He graduated with a B.S. from the University of California, Irvine.

Leandra Hutchinson

President, Direct Radiology

Leandra Hutchinson joined ONRAD alongside the acquisition of Direct Radiology in December 2024. Hutchison has broad experience in the healthcare industry, spending her career in healthcare technology and innovation. Prior to joining Direct Radiology in 2019, Leandra was the co-founder and Vice President of Operations of a health-tech company specializing in radiology analytics and healthcare asset management. Previously, Leandra worked in marketing, strategy, and operations roles for more than 10 years at a $7B integrated delivery system of hospitals and medical centers with more than 900 employed physicians. Hutchison earned her Bachelor’s degree from Kent State University and graduate certificate in health care policy and administration and MBA from the University of Toledo.

Ron Jackson

President, AllRads

Ron Jackson serves as President of AllRads at ONRAD, bringing over 30 years of comprehensive healthcare leadership across the provider, payer, and technology landscape. With deep expertise in radiology, he has spent more than 25 years in revenue cycle management, operations, finance, and practice management roles at leading organizations including HBOC, Per-Se Technologies, McKesson, and Zotec Partners. At ONRAD, Jackson leads day-to-day operations and strategic execution of AllRads, drawing on his cross-functional experience to drive efficiency, scalability, and growth. His 360-degree perspective of the healthcare ecosystem uniquely positions him to align organizational strategy with market dynamics in teleradiology and imaging services.

Alix Vincent, M.D.

Chief Medical Officer

Dr. Alix Vincent was one of the founding physicians at ONRAD. With over 26 years of radiology leadership experience, Dr. Vincent oversees medical staff activities, including patient safety, quality, and risk management initiatives. He manages ONRAD’s Regional Medical Directors, evaluates staff physicians, and drives clinical improvements to enhance physician alignment within the organization. Additionally, Dr. Vincent leads medical operations and played a key role in developing the company’s PACS and RIS Network capabilities. He previously served as Chief Radiologist and Chairman of the Radiology Department at Riverside Regional Medical Center. Dr. Vincent holds an M.D. in Radiology from Loma Linda University.

Lyn Mize

Chief Financial Officer

Lyn Mize serves as Chief Financial Officer at ONRAD, a role she has held since June 2022. With over two decades of experience in financial leadership, Mize has held CFO positions at various healthcare organizations, including Sunset Media Entertainment and Oncology Convergence, Inc. She also served as Vice President of Accounting at Health Choice and System Director of Accounting at Scottsdale Healthcare. Mize has a strong background in financial management, having worked with Banner Health and Greeley Medical Clinic, where she provided financial leadership for multi-specialty clinics and physician networks. Mize holds extensive expertise in driving financial performance and strategic growth across the healthcare sector and has a B.S. from DeVry University and a Masters from Grand Canyon University.

Dave Engert

President & CEO

Dave Engert started at Onrad as President and CEO in 2017. Engert is a seasoned healthcare executive with over 35 years of experience and a proven track record of leading and transforming healthcare technology organizations to drive growth and improve operational and financial performance. He previously served as President and CEO of Nighthawk Radiology, the largest teleradiology provider, and led its successful sale to vRad. Engert also held the role of President and CEO of Quality Care Solutions (QCSI), a leading provider of health insurance software, which was sold to Trizetto. Additionally, he has held leadership roles at McKesson, HBOC, and other notable companies and invested in several healthcare technology ventures. Engert holds a B.S. in Industrial Engineering from Louisiana State University.